Articles Tagged With:
-
Chondroitin Is as Effective as Celecoxib for Knee Arthritis
Six months of 800 milligrams of pharmaceutical-grade chondroitin sulfate daily relieved knee pain as much as 400 milligrams of celecoxib.
-
Decisional Conflict Common for Surrogates of ICU Patients
A recent study looked at whether the decision-making process plays a role in the psychological morbidity associated with being a surrogate in the ICU.
-
Paper Calls for More Transparency of Industry-sponsored Clinical Trials
A recent paper offers consensus recommendations and examples of best practices from the published clinical trial literature to help authors and trial sponsors communicate drug adverse events in a more informative and clinically meaningful manner.
-
Are Patients Prepared for Reality of Life With Implantable Devices?
Patients may view cardiac implantable electronic devices as a lifesaver — without fully understanding quality of life issues.
-
Study Identifies Surprising Priorities of Chronically Critically Ill Patients
For chronically critically ill patients and their surrogates, life prolongation fell below cognitive impact and physical function goals for the majority of people surveyed. This was true for both patients and families.
-
Study: COPD Symptom Burden Often Goes Unrecognized
Patients with chronic obstructive pulmonary disease often experience symptom burden and social isolation that is underappreciated by clinicians, are much more likely than lung cancer patients to die in hospital than at home, and they often lack palliative care, found a recent study.
-
‘We Want Everything Possible Done for Mom’
Joanne Lynn, MD, a Washington, DC-based geriatrician and director of the Center for Elder Care and Advanced Illness at Altarum Institute, has dedicated her career to finding ways to improve health and healthcare at a sustainable cost. Lynn tells Medical Ethics Advisor how hospitals can achieve ethical end-of-life care.
-
New Resuscitation Policy: It’s Not Offered Unless Clinically Indicated
Ethicists at University of Virginia helped develop a new resuscitation policy stating that patients or surrogates can accept or refuse offered treatment, and that the healthcare team should not offer treatments unless clinically indicated.
-
Patients Who Refuse Discharge Are ‘Disaster in the Making’
Patients refusing to leave the hospital for weeks, or even months — despite being medically cleared for discharge — are a growing problem, according to ethicists.
-
Left Ventricular Volume Affects Function in Chemotherapy Patients
Reductions in left ventricular ejection fraction in patients receiving potentially cardiotoxic chemotherapy may be because of significant decreases in left ventricular volume in up to 20% of these patients.